Entry0.0129→Now0.0134
PRV sales plus Fayuvi imply RARE worth ~$21 Open original source
RARE SuperRare Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
20:53
Oct 18
Oct 18
r/wallstreetbets
PRV sales plus Fayuvi imply RARE worth ~$21
Author argues Ultragenyx is undervalued after its Angelman trial selloff to ~$14, because roughly $371M net from two PRV sales plus ~$275M in Fayuvi peak sales potential equal about 45% of the $1.43B market cap, implying fair value near $21. Technical resistance at $18 supports a conservative $17.90 target, and ~22% short interest with majority institutional ownership could add upward pressure. Main risk is the author's own admission of limited financial acumen and continued biotech sector pressure (XBI) that may push the stock below $14.50.
RARE
SuperRare
Long
1ST
Position: Opened
—
17:09
Sep 18
Sep 18
r/wallstreetbets
RARE undervalued after FDA approval news
The author picked up more 10/16 $20 calls on RARE, arguing the stock should be trading higher, especially following yesterday's FDA approval news. The catalyst is the recent FDA approval, with the author expressing patience via the October expiry. The main risk implied is that the market has not yet repriced the news higher.
RARE
SuperRare
Long
—
—
14:45
Sep 18
Sep 18
r/wallstreetbets
RARE short squeeze after FDA approval
The author states RARE is undergoing a short squeeze today, attributing the move to an FDA approval received the previous day. The mechanism is a squeeze: shorts forced to cover after a positive regulatory catalyst drives outsized upside. The stated catalyst is the FDA approval; no explicit time horizon beyond 'today' and no stated risk are given.
RARE
SuperRare
Long
1ST
—
—
About RARE Investor Commentary
Across the available history and selected sources, Buzzberg tracks RARE (SuperRare) across 7 sources: 6 bullish vs 1 bearish calls from 10 authors. Historical directional balance: 31% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 16 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/Delicious-Drag3009, u/tldamico, u/hblais11.